Development of Human Pluripotent Stem Cell-Derived Hepatic Organoids as an Alternative Model for Drug Safety Assessment

Researchers generated human PSC-derived hepatic organoids (hHOs) with a high drug metabolic ability. They established a two-step protocol to produce hHOs from human pluripotent stem cells for long-term expansion and drug testing.